Sudden cardiac death after myocardial infarction in patients with type 2 diabetes

被引:79
作者
Junttila, M. Juhani [1 ,2 ]
Barthel, Petra [2 ,3 ,4 ]
Myerburg, Robert J. [1 ]
Makikallio, Timo H. [2 ]
Bauer, Axel [3 ,4 ]
Ulm, Kurt [5 ]
Kiviniemi, Antti [6 ]
Tulppo, Mikko [6 ]
Perkiomaki, Juha S. [2 ]
Schmidt, Georg
Huikuri, Heikki V. [2 ,3 ,4 ]
机构
[1] Univ Miami, Miller Sch Med, Div Cardiol, Miami, FL 33101 USA
[2] Univ Oulu, Dept Internal Med, Inst Clin Med, SF-90220 Oulu, Finland
[3] Tech Univ Munich, Deutsch Herzzentrum, Munich, Germany
[4] Tech Univ Munich, Med Klin 1, Munich, Germany
[5] Tech Univ Munich, Inst Med Stat & Epidemiol, Munich, Germany
[6] Verve, Dept Exercise & Med Physiol, Oulu, Finland
基金
芬兰科学院;
关键词
Diabetes Mellitus; Myocardial infarction; Prognosis; Sudden death; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; CARDIOVASCULAR RISK; MORTALITY; PREDICTION; DISEASE; STRATIFICATION; MELLITUS;
D O I
10.1016/j.hrthm.2010.07.031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Type 2 diabetes mellitus is a well-established risk factor for atherosclerosis, but its contribution to sudden cardiac death (SCD) risk after myocardial infarction (MI) is not well defined. OBJECTIVE The purpose of this study was to compare the incidence and time-dependent risk of SCD in diabetic patients versus nondiabetic patients during 5-year follow-up after acute MI. METHODS A total of 3,276 patients were enrolled at the time of acute MI between 1996 and 2005. Mean age at entry was 60 +/- 11 years, and the cohort was followed until 2009. At entry into the study, diabetes was present in 629 (19.2%) patients. The primary endpoint was SCD, and the secondary endpoints were non-SCD and all-cause mortality. RESULTS Among diabetic patients, the incidence of SCD was higher (5.9%) than in nondiabetic patients (1.7%), with a hazard ratio (HR) of 3.8 (95% confidence interval [CI] 2.4-5.8; P <.001) and adjusted HR of 2.3 (95% CI 1.4-3.8; P <.01). In diabetic patients with left ventricular ejection fraction >35%, the incidence of SCD was nearly identical to that of nondiabetic patients with ventricular ejection fraction <= 35% (4.1% vs 4.9%; P = .48). An excess in the incidence of non-SCD began to appear among diabetic patients within the first 6 months of follow-up (P <.001) but not in the incidence of SCD (P = .09). The excess in SCD among diabetic patients began to appear more than 6 months after the index event. CONCLUSION Patients with type 2 diabetes are at higher risk for SCD after MI than are nondiabetic patients. The incidence of SCD in post-MI type 2 diabetic patients with left ventricular ejection fraction >35% is equal to that of nondiabetic patients with left ventricular ejection fraction <35%.
引用
收藏
页码:1396 / 1403
页数:8
相关论文
共 29 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]   Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].
Bardy, GH ;
Lee, KL ;
Mark, DB ;
Poole, JE ;
Packer, DL ;
Boineau, R ;
Domanski, M ;
Troutman, C ;
Anderson, J ;
Johnson, G ;
McNulty, SE ;
Clapp-Channing, N ;
Davidson-Ray, LD ;
Fraulo, ES ;
Fishbein, DP ;
Luceri, RM ;
Ip, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237
[4]   Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk) [J].
Bauer, Axel ;
Barthel, Petra ;
Schneider, Raphael ;
Ulm, Kurt ;
Mueller, Alexander ;
Joeinig, Anke ;
Stich, Raphael ;
Kiviniemi, Antti ;
Hnatkova, Katerina ;
Huikuri, Heikki ;
Schoemig, Albert ;
Malik, Marek ;
Schmidt, Georg .
EUROPEAN HEART JOURNAL, 2009, 30 (05) :576-583
[5]   Determinants of Prolonged QT Interval and Their Contribution to Sudden Death Risk in Coronary Artery Disease The Oregon Sudden Unexpected Death Study [J].
Chugh, Sumeet S. ;
Reinier, Kyndaron ;
Singh, Tejwant ;
Uy-Evanado, Audrey ;
Socoteanu, Carmen ;
Peters, Dawn ;
Mariani, Ronald ;
Gunson, Karen ;
Jui, Jonathan .
CIRCULATION, 2009, 119 (05) :663-670
[6]   Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies [J].
Evans, JMM ;
Wang, JX ;
Morris, D .
BRITISH MEDICAL JOURNAL, 2002, 324 (7343) :939-942A
[7]   Noninvasive risk assessment early after a myocardial infarction [J].
Exner, Derek V. ;
Kavanagh, Katherine M. ;
Slawnych, Michael P. ;
Mitchell, L. Brent ;
Ramadan, Darlene ;
Aggarwal, Sandeep G. ;
Noullett, Catherine ;
Van Schaik, Allie ;
Mitchell, Ryan T. ;
Shibata, Mariko A. ;
Gulamhussein, Sajad ;
McMeekin, James ;
Tymchak, Wayne ;
Schnell, Gregory ;
Gillis, Anne M. ;
Sheldon, Robert S. ;
Fick, Gordon H. ;
Duff, Henry J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (24) :2275-2284
[8]   ARRHYTHMOGENIC EFFECTS OF GRADED CORONARY BLOOD-FLOW REDUCTIONS SUPERIMPOSED ON PRIOR MYOCARDIAL-INFARCTION IN DOGS [J].
FURUKAWA, T ;
MOROE, K ;
MAYROVITZ, HN ;
SAMPSELL, R ;
FURUKAWA, N ;
MYERBURG, RJ .
CIRCULATION, 1991, 84 (01) :368-377
[9]   Risk stratification for primary implantation of a Cardioverter-Defibrillator in patients with ischemic left ventricular dysfunction [J].
Goldenberg, Ilan ;
Vyas, Anant K. ;
Hall, W. Jackson ;
Moss, Arthur J. ;
Wang, Hongyue ;
He, Hua ;
Zareba, Wojciech ;
McNitt, Scott ;
Andrews, Mark L. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (03) :288-296
[10]   Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].
Haffner, SM ;
Lehto, S ;
Rönnemaa, T ;
Pyörälä, K ;
Laakso, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234